C-MER Medical (03309) announced that the group expects to achieve profit attributable to equity holders of the company of approximately HK$46-52 million for the first half of 2025, representing an increase of approximately 49% to 69% compared to the same period last year.

The expected increase in profit attributable to company shareholders is primarily driven by revenue rising slightly from HK$922.5 million in the corresponding period last year to approximately HK$940 million in the first half of 2025. The improvement also benefits from the significant effectiveness of the company's strategies to optimize its service network and enhance operational efficiency, including closing underperforming businesses and implementing cost-saving measures.